More than eight hundred million people worldwide have chronic liver disease, with two
million deaths per year. Recurring liver injury results in fibrogenesis, progressing towards …

Extracellular vesicles (EVs) are membranous vesicles originating from different cells in the
liver. The pathophysiological role of EVs is increasingly recognized in liver diseases …

Fatty liver diseases, non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease
(ALD) are the most common causes of chronic liver diseases around the world. NAFLD and …

Extracellular vesicles (EVs) are membrane-derived vesicles which can be released by
different cell types, including hepatocytes, hepatic stellate cells and immune cells in normal …

Since the first descriptions of hepatocyte-released exosome-like vesicles in 2008, the
number of publications describing Extracellular Vesicles (EVs) released by liver cells in the …

Extracellular vesicles (EVs) are membrane-defined nanoparticles released by most cell
types. The EVs released by cells may differ quantitatively and qualitatively from …

Extracellular vesicles (EVs) are endogenous nanoparticles that play important roles in
intercellular communication. Unmodified and engineered EVs can be utilized for therapeutic …

Extracellular vesicles (EVs) are a heterogeneous population of small membrane vesicles
released by all types of cells in both physiological and pathological conditions. EVs shuttle …

As the largest vital solid organ in the body, liver is consisting of multiple types of cells
including hepatocytes, Kupffer cell, hepatic stellate cells (HSCs), liver sinusoidal endothelial …

Extracellular vesicles (EVs) are membrane-derived vesicles released by a variety of cell
types, including hepatocytes, hepatic stellate cells, and immune cells in normal and …